Ribon Therapeutics picks up $65m
Ribon Therapeutics, a clinical stage biotechnology company, has secured $65 million in financing.
Ribon Therapeutics, a clinical stage biotechnology company, has secured $65 million in financing.
Copyright PEI Media
Not for publication, email or dissemination